Journal

Hyperkalemia in chronic kidney disease

Read time: 1 mins

Published: 12th Jan 2020

Author: Watanabe R.

Source: Revista da Associação Médica Brasileira

Availability: Free full text

Ref.: Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s31-s36.

DOI: 10.1590/1806-9282.66.S1.31

Hyperkalemia in chronic kidney disease

Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD). This increase in serum potassium levels is associated with decreased renal ion excretion, as well as the use of medications to reduce the progression of CKD or to control associated diseases such as diabetes mellitus and heart failure. Hyperkalemia increases the risk of cardiac arrhythmia episodes and sudden death. Thus, the control of potassium elevation is essential for reducing the mortality rate in this population. Initially, the management of hyperkalemia includes orientation of low potassium diets and monitoring of patients' adherence to this procedure. It is also important to know the medications in use and the presence of comorbidities to guide dose reduction or even temporary withdrawal of any of the potassium retention-related drugs. And finally, the use of potassium binders is indicated in both acute episodes and chronic hyperkalemia.

Read abstract on library site Access full article

A blood draw being performed on the inside of a person's arm; testing for hyperkalaemia

Hyperkalemia

Disease information, latest news, and guidelines

A digital image of two human kidneys, stylised in blue and red

Chronic kidney disease

Expert insights on diagnosis and novel treatments

Digital close up of human kidney glomerulus and the Bowman Capsule

Glomerulonephritis

Unmet needs, latest news, and guideline updates

Featured Learning Zones

patient receiving dialysis, hospital image

Learning Zone

Chronic Kidney Disease Learning Zone

Chronic Kidney Disease (CKD) is a disease that can often lead to a need for haemodialysis and kidney transplantation. New CKD treatments are emerging which focus on delaying CKD disease progression and the need for transplantation.

Learning Zone Homepage

Fluid Management Learning Zone

Welcome to the Fluid Management Learning Zone. In this Learning Zone we provide an overview of fluid management, including albumin for sepsis and septic shock, guidelines for fluid management in liver cirrhosis and fluid management in cardiac surgery.

You may be interested in...

Guideline

Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

The joint AAD–NPF guideline provides evidence‑based recommendations for the use of topical therapies and select alternative medicine approaches in psoriasis management. It offers updated guidance on severity assessment measures, treatment selection, and patient‑centred approaches to optimise outcomes in mild‑to‑moderate disease.

Guideline

French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025

These updated French guidelines provide new decision‑making algorithms for systemic treatment of moderate‑to‑severe psoriasis in adults. They incorporate recent evidence, integrate emerging systemic therapies, and offer recommendations for plaque psoriasis, psoriatic arthritis, comorbidities and special situations such as pregnancy.

Guideline

S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm - part 2: Specific clinical and comorbid situations

The EuroGuiDerm‑adapted S3 guideline part 2 provides recommendations for treating psoriasis vulgaris in patients with specific clinical presentations or comorbidities. It addresses management in pregnancy, infection risk, metabolic syndrome, organ‑specific disease, and difficult‑to‑treat areas, offering expert‑driven practical guidance.